CD200 R1

CD200 R1

CD200 R1 Molekülinformation

Molecule Name
Cell surface glycoprotein CD200 receptor 1
Molekülalias
CD200R,CRTR2,MOX2R,OX2R
Drug Development Progress
Anzahl der klinischen Arzneimittel4
Anzahl der inverkehr gebrachten Arzneimittel0
Höchste Forschungs- und EntwicklungsphasePhase 2 Clinical
Target-Alias
Cell surface glycoprotein OX2 receptor 1,CD200 cell surface glycoprotein receptor,CD200R
Molekülhintergrund
Cell surface glycoprotein CD200 receptor 1 is a protein that in humans is encoded by the CD200R1 gene. This gene encodes a receptor for the OX-2 membrane glycoprotein. Both the receptor and substrate are cell surface glycoproteins containing two immunoglobulin-like domains. This receptor is restricted to the surfaces of myeloid lineage cells and the receptor-substrate interaction may function as a myeloid downregulatory signal. CD200 and its receptor CD200R are both type-1 membrane glycoproteins, which are members of the immunoglobulin superfamily (IgSF). Besides the inhibitory effect on macrophages, CD200/CD200R also play an important role in regulating the regulatory T cells, allergicreaction, autoimmune diseases, allograft, neurological diseases and other autoimmune-related diseases. The interaction between CD200, which is mainly present in neurons but also in astrocytes, and CD200R1, which is mainly present in microglia, is one of the mechanisms involved in keeping the microglial proinflammatory phenotype under control in physiological conditions. Alterations in the expression of CD200 and CD200R1 have been described in neurodegenerative diseases, but little is known about the mechanism of regulation of these proteins under physiological or pathological conditions.

CD200 R1 Produktliste

Species
  • Human(2)
Tag
  • Fc Tag & Avi Tag(1)
  • His Tag(1)
Host
  • HEK293(2)
Conjugate
  • Biotin-labeled(1)
  • Unconjugated(1)
Grade
  • RUO(2)
Low Endotoxin
  • Yes(1)
  • No(1)
MoleculeCat. No.Product NameArtHostStructurePurityActivitySize&PriceAdd to Cart
CD200 R1
Human CD200 R1 / CRTR2 Protein, His Tag, low endotoxin (MALS verified)
Human
HEK293
MALSSDS-PAGE
ELISA

$360.00

100ug
CD200 R1
Avitag
CR2-H82F4
Biotinylated Human CD200 R1 / CRTR2 Protein, Fc,Avitag™
Human
HEK293
SDS-PAGE
ELISA

$360.00

25ug
You Have Viewed 1-2 Of 2 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Asset Licensing Opportunity

Lizenzierungszusammenarbeit

ProjektnameArzneimitteltypTherapiegebietIndikationenStufeRechtsgebiet
High selective OX1R/OX2R dual inhibitor treating insomniaSmall moleculeNeurological diseaseInsomniaPhase IGlobal
Arzneimitteltyp
Small molecule
Therapiegebiet
Neurological disease
Indikationen
Insomnia
Stufe
Phase I
Rechtsgebiet
Global
Resources

Klinische Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaIndikationenKlinische Studie
P-00623ME-00610; P-006; 23ME’610Phase 2 Clinical23andme Inc
Carcinoma, Ovarian Epithelial; Carcinoma, Renal Cell; Fallopian Tube Neoplasms; Microsatellite instability-high cancer; Neuroendocrine Tumors; Peritoneal Neoplasms; Small Cell Lung Carcinoma; Solid tumours
Details
GS-5305GS-5305Phase 1 ClinicalGilead Sciences Lda
Inflammation
Details
DS-234DS-234; ARQ-234Phase 1 ClinicalDucentis BioTherapeutics Ltd
Dermatitis, Atopic; Eczema
Details
UcenprubartLY-3454738Phase 1 ClinicalEli Lilly And Company
Chronic Urticaria; Dermatitis, Atopic
Details
Customer Reviews